查詢結果分析
來源資料
相關文獻
- The Use of Prophylactic Intravenous Immunoglobulin Therapy in Very Low Birthweight Infants
- Staphylococcus capitis Bacteremia of Very Low Birth Weight Premature Infants at Neonatal Intensive Care Units: Clinical Significance and Antimicrobial Susceptibility
- Efffect of Erythromycin on Feeding Intolerance in Very Low Birth Weight Infants: A Preliminary Observation
- The Anesthetic Management of A Preterm Infant Weighing 500 Grams Undergoing Ligation of Patent Ductus Arteriosus--A Case Report
- Glucose and Insulin Infusion Versus Kayexalate for the Early Treatment of Non-oliguric Hyperkalemia in Very-Low-Birth-Weight Infants
- 極低體重早產兒肺出血之探討
- Intraventricular Hemorrhage, Periventricular Leukomalacia and Hypoglycemia in Very Low Birth Weight Infants: Relationship to Neurodevelopment at Two Years of Age
- Type 1 Autoimmune Hepatitis Mimic Cryptogenic Hepatitis
- Sepsis in the Very Low Birth Weight Infants in Taiwan
- 談日本1000公克以下極低體重早產兒7-9歲的追蹤成果
頁籤選單縮合
題 名 | The Use of Prophylactic Intravenous Immunoglobulin Therapy in Very Low Birthweight Infants=使用預防性靜注免疫球蛋白療法於極低體重早產兒 |
---|---|
作 者 | 周怡宏; 鄒國英; | 書刊名 | 長庚醫學 |
卷 期 | 21:4 1998.12[民87.12] |
頁 次 | 頁371-376 |
分類號 | 417.5171 |
關鍵詞 | 靜注免疫球蛋白; 極低體重早產兒; 免疫球蛋白G; Intravenous immunoglobulin; Very low birthweight infants; Immunoglobulin G; |
語 文 | 英文(English) |
中文摘要 | 背景:極低體重早產兒因其免疫系統發展之不成熟及住入加護病房內接受種種侵 害性治療,使其易受院內感染之侵襲,因此吾人嘗試以預防性免疫球蛋白療法,期望減低其 感染率。 方法:此一前瞻性研究共收錄61位極低體重早產兒(出生體重<1500公克),並分為二組,一 為研究組(n=31)及另一為控制組(n=30)。對體重1000公克以下者,給予750∼1000 mg/kg, 而1000∼1500公克者,給予500∼750 mg/kg,其間隔為每2週使用1次,直至體重1800公克或 出院為止。免疫球蛋白G之測量則依一定期間予以抽血- -出生時、7天、14天、21天、28天 、35天、42天、49天、及56天。確定性敗血症則定義為菌血症(陽性血液或脊髓培養)併有臨 床或血行動力學之惡化。其他記錄則包含周產期及新生兒之種種特徵,感染率以及培養菌種 呈陽性者。 結果:此一研究結果如下:(1)研究及控制組之周產期及新生兒特徵並無不同;(2)只有在研 究組才發現有持續維持之血中IgG濃度;(3)在研究組之首次確定性敗血症之發生時間比控制 者來得晚;(4)感染率在兩組則無差異,而研究組病例中住院逾60日者則較少。 結論:本研究中之極低體重早產兒較足月兒之血中IgG濃度為低,而使用預防性免疫球蛋白 療法雖可維持較高之血中IgG濃度,但對感染率之減低並無預防之效果。 |
英文摘要 | Background: Nosocomial infections are a major cause of death in premature infants, especially in very low birthweight(VLBW) infants. The VLBW infants have low serum immunoglobulin G levels, which may have an effect on infections in early infancy. Thus, prophylactic administration of intravenous immunoglobulin(IVIG) is proposed to maintain higher immunoglobulin G and reduce the rate of hospital-acquired infection. Materials and Methods: A study for the effects of prophylactic IVIG therapy in VLBW infants was performed. A total of 61 VLBW infants were enrolled,and divided into the IVIG group(n=31) and the control group(n=30). The dose for each infant was 750-1000 mg/kg for those whose birthweight was less than 1000g, and 500-750 mg/kg for infants whose birthweight was between 1001 and 1500g. The control group received saline infusion. The infusions were given every 2 weeks until the infant weighed 1800g, or was discharged. Results: The results showed: there were no major differences in the perinatal and neonatal characteristics between the two groups, consistently higher IgG levels were found in the IVIG group, and the age of first documented sepsis was earlier in the control group. Conclusion: In this study, the prophylactic IVIG therapy may give substantially higher IgG levels, which may last for 2 months. However, a prophylactic effect for hospital-acquired infections was not observed. |
本系統中英文摘要資訊取自各篇刊載內容。